Stryker Corporation $SYK Shares Sold by Candriam S.C.A.

Candriam S.C.A. trimmed its stake in Stryker Corporation (NYSE:SYK) by 0.9% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 177,434 shares of the medical technology company’s stock after selling 1,643 shares during the quarter. Candriam S.C.A.’s holdings in Stryker were worth $65,592,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Brighton Jones LLC raised its holdings in Stryker by 15.4% during the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after buying an additional 609 shares during the period. IFP Advisors Inc increased its position in shares of Stryker by 1.2% in the second quarter. IFP Advisors Inc now owns 2,657 shares of the medical technology company’s stock worth $1,051,000 after acquiring an additional 31 shares in the last quarter. Fifth Third Wealth Advisors LLC increased its position in shares of Stryker by 8.1% in the second quarter. Fifth Third Wealth Advisors LLC now owns 5,612 shares of the medical technology company’s stock worth $2,220,000 after acquiring an additional 422 shares in the last quarter. Manitou Investment Management Ltd. raised its holdings in shares of Stryker by 0.3% during the second quarter. Manitou Investment Management Ltd. now owns 50,118 shares of the medical technology company’s stock valued at $19,828,000 after acquiring an additional 166 shares during the period. Finally, 1858 Wealth Management LLC lifted its position in shares of Stryker by 7.2% in the 2nd quarter. 1858 Wealth Management LLC now owns 578 shares of the medical technology company’s stock valued at $229,000 after acquiring an additional 39 shares in the last quarter. 77.09% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have weighed in on SYK. Barclays reiterated an “overweight” rating and set a $469.00 price objective on shares of Stryker in a research report on Monday, February 2nd. Citizens Jmp raised Stryker from a “market perform” rating to an “outperform” rating and set a $440.00 price objective for the company in a research note on Friday, December 19th. Citigroup reaffirmed a “market outperform” rating on shares of Stryker in a research note on Friday, January 30th. The Goldman Sachs Group set a $399.00 target price on Stryker in a report on Friday, January 9th. Finally, Evercore set a $390.00 price target on shares of Stryker in a report on Monday, January 5th. Twelve investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $426.94.

Stryker Stock Down 1.1%

Stryker stock opened at $358.49 on Monday. The company has a market capitalization of $137.09 billion, a P/E ratio of 42.68, a P/E/G ratio of 2.10 and a beta of 0.87. Stryker Corporation has a 1-year low of $329.16 and a 1-year high of $404.87. The firm’s fifty day simple moving average is $358.39 and its 200-day simple moving average is $370.46. The company has a current ratio of 1.89, a quick ratio of 1.21 and a debt-to-equity ratio of 0.66.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, beating the consensus estimate of $4.40 by $0.07. The company had revenue of $7.17 billion for the quarter, compared to analyst estimates of $7.12 billion. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The business’s revenue was up 11.4% compared to the same quarter last year. During the same period last year, the company earned $4.01 earnings per share. Sell-side analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a yield of 1.0%. Stryker’s dividend payout ratio is presently 41.90%.

Insider Activity

In related news, CAO William E. Berry, Jr. sold 1,953 shares of Stryker stock in a transaction on Friday, November 14th. The shares were sold at an average price of $365.49, for a total value of $713,801.97. Following the transaction, the chief accounting officer owned 2,833 shares in the company, valued at $1,035,433.17. This trade represents a 40.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Ronda E. Stryker sold 250,000 shares of the business’s stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the transaction, the director directly owned 2,457,331 shares of the company’s stock, valued at approximately $891,814,566.52. This represents a 9.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 252,118 shares of company stock valued at $91,504,172 over the last 90 days. 5.20% of the stock is currently owned by company insiders.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.